| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |